Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.6.5 is now shown on the page, replacing Revision: v3.6.4. This indicates a small update to the page's revision metadata for the study details view.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a new revision tag: Revision: v3.6.4, replacing the previous v3.6.3. This reflects a site update rather than changes to the study details.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now displays Revision: v3.6.3 in place of Revision: v3.6.2, updating the site's version label. This documents a minor version update to the system label used on the page.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.6.2 is now displayed on the page, signaling a minor platform update. This change does not modify study content or how the page appears to users.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now indicates recruitment is closed and introduces new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), plus a revision notice.SummaryDifference0.3%

- Check69 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating a small maintenance update to the study record page.SummaryDifference0.0%

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.